| [1] Dursun CK,Dursun E,Eratalay K,et al.Effect of Porous Titanium Granules on Bone Regeneration and Primary Stability in Maxillary Sinus: A Human Clinical, Histomorphometric, and Microcomputed Tomography Analyses.J Craniofac Surg.2016;27(2):391-397.[2] Dursun E,Keceli HG,Uysa Sl,et al.Management of Limited Vertical Bone Height in the Posterior Mandible: Short Dental Implants Versus Nerve Lateralization With Standard Length Implants.J Craniofac Surg. 2016;27(3):578-585.[3] 闫怡轩.种植体表面生物活性涂层的研究现状及进展[J].全科口腔医学杂志(电子版),2017,4(12):10-12.[4] Ma T,Ge XY,Hao KY,et al.Simple 3,4-Dihydroxy-L-Phenylalanine Surface Modification Enhances Titanium Implant Osseointegration in Ovariectomized Rats.Sci Rep.2017;7(1):17849.[5] 邢帅,高延征,高坤,等.双膦酸盐类药物治疗原发性骨质疏松症研究进展[J].风湿病与关节炎,2016, 5(3):70-73.[6] Marin-Fernandez AB,Garcia Medina B,Aguilar-Salvatierra A,et al.Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid.J Clin Exp Dent. 2015; 7(3):e444-446.[7] de Oliveira MA,Asahi DA,Silveira CA,et al.The effects of zoledronic acid and dexamethasone on osseointegration of endosseous implants: histological and histomorphometrical evaluation in rats. Clin Oral Implants Res.2015;26(4):e17-21.[8] Dundar S,Yaman F,Gecor O,et al.Effects of Local and Systemic Zoledronic Acid Application on Titanium Implant Osseointegration: An Experimental Study Conducted on Two Surface Types. J Craniofac Surg.2017;28(4):935-938.[9] 阴露佳,林珏杉,温黎明,等.唑来膦酸对破骨细胞分化中钙调蛋白、钙调磷酸酶表达的影响[J].南京医科大学学报(自然科学版), 2016,61(2): 171-175.[10] Zhu M,Zhu Y,Ni B,et al.Mesoporous silica nanoparticles/hydroxyapatite composite coated implants to locally inhibit osteoclastic activity.ACS Appl Mater Interfaces.2014;6(8):5456-5466.[11] Tai TW,Chen CY,Su FC,et al.Reactive oxygen species are required for zoledronic acid-induced apoptosis in osteoclast precursors and mature osteoclast-like cells.Sci Rep. 2017;7:44245.[12] 庞雪,刘英,曹积弘,等.唑来膦酸治疗绝经后骨质疏松症的一过性反应的观察与护理[J].中国骨质疏松杂志, 2013,19(11): 1187-1189.[13] Ardine M,Generali D,Donadio M,et al.Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw? Ann Oncol. 2006; 17(8):1336-1337.[14] Abe K,Yoshimura Y,Deyama Y,et al.Effects of bisphosphonates on osteoclastogenesis in RAW264.7 cells.Int J Mol Med. 2012;29(6): 1007-1015.[15] 李鹏飞,杨虎,贾楠,等.基于唑来膦酸对破骨细胞抑制特征的实验研究[J].生物医学工程学杂志,2017,34(1): 78-82.[16] Murphy CM,Schindeler A,Gleeson JP,et al.A collagen-hydroxyapatite scaffold allows for binding and co-delivery of recombinant bone morphogenetic proteins and bisphosphonates.Acta Biomater. 2014; 10(5):2250-2258.[17] Dedes PG,Kanakis I,Gialeli C,et al.Preclinical evaluation of zoledronate using an in vitro mimetic cellular model for breast cancer metastatic bone disease.Biochim Biophys Acta. 2013;1830(6): 3625-3634.[18] 吴骁伟,李少晗,曹文娟.唑来膦酸影响单个核细胞向破骨细胞分化及RANK表达的研究[J].中华全科医学, 2016,14(10):1644-1646.[19] Maruotti N,Corrado A,Neve A,et al.Bisphosphonates: effects on osteoblast.Eur J Clin Pharmacol.2012;68(7):1013-1018.[20] Reinholz GG,Getz B,Pederson L,et al.Bisphosphonates directly regulate cell proliferation, differentiation, and gene expression in human osteoblasts.Cancer Res. 2000;60(21):6001-6007.[21] Giuliani N,Pedrazzoni M,Negri G,et al.Bisphosphonates stimulate formation of osteoblast precursors and mineralized nodules in murine and human bone marrow cultures in vitro and promote early osteoblastogenesis in young and aged mice in vivo.Bone. 1998; 22(5):455-461.[22] Furlaneto FA,Nunes NL,Oliveira Filho IL,et al.Effects of locally administered tiludronic acid on experimental periodontitis in rats.J Periodontol.2014;85(9):1291-1301.[23] Dalle Carbonare L,Mottes M,Malerba G,et al.Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients.Int J Mol Sci.2017;18(6):1261.[24] Soto SA,Barbará AC.Bisphosphonates: Pharmacology and Clinical Approach to Their Use in Equine Osteoarticular Diseases.J Equine Vet Sci.2014;34(6):727-737.[25] Greiner S,Kadow-Romacker A,Lubberstedt M,et al.The effect of zoledronic acid incorporated in a poly(D,L-lactide) implant coating on osteoblasts in vitro.J Biomed Mater Res A. 2007;80(4):769-775.[26] Gao Y,Zou S,Liu X,et al.The effect of surface immobilized bisphosphonates on the fixation of hydroxyapatite-coated titanium implants in ovariectomized rats. Biomaterials. 2009;30(9):1790-1796.[27] Greiner S,Kadow-Romacker A,Schmidmaier G,et al.Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating. J Biomed Mater Res A. 2009;91(1):288-295.[28] Ayan M,Dolanmaz D,Mihmanli A,et al.The effect of systemically administrated zoledronic acid on the osseointegration of dental implants.Oral Dis. 2012;18(8):802-808.[29] Dikicier E,Karacayli U,Dikicier S,et al.Effect of systemic administered zoledronic acid on osseointegration of a titanium implant in ovariectomized rats.J Craniomaxillofac Surg. 2014;42(7): 1106-1111.[30] Carvas JS,Pereira RM,Caparbo VF,et al.A single dose of zoledronic acid reverses the deleterious effects of glucocorticoids on titanium implant osseointegration. Osteoporos Int.2010; 21(10):1723-1729.[31] Huja SS,Kaya B,Mo X, et al.Effect of zoledronic acid on bone healing subsequent to mini-implant insertion.Angle Orthod. 2011;81(3): 363-369.[32] Stadlinger B,Korn P,Todtmann N,et al.Osseointegration of biochemically modified implants in an osteoporosis rodent model.Eur Cell Mater.2013;25:326-340;discussion 339-340.[33] Cuairan C,Campbell PM,Kontogiorgos E,et al.Local application of zoledronate enhances miniscrew implant stability in dogs.Am J Orthod Dentofacial Orthop. 2014;145(6):737-749.[34] Ying G,Bo L,Yanjun J,et al.Effect of a local, one time, low-dose injection of zoledronic acid on titanium implant osseointegration in ovariectomized rats.Arch Med Sci. 2016;12(5):941-949.[35] Miettinen SS,Jaatinen J,Pelttari A,et al.Effect of locally administered zoledronic acid on injury-induced intramembranous bone regeneration and osseointegration of a titanium implant in rats. J Orthop Sci. 2009; 14(4):431-436.[36] Friedl G,Radl R,Stihsen C,et al.The effect of a single infusion of zoledronic acid on early implant migration in total hip arthroplasty. A randomized, double-blind, controlled trial.J Bone Joint Surg Am. 2009; 91(2):274-281.[37] Blazsek J,Dobo Nagy C,Blazsek I,et al.Aminobisphosphonate stimulates bone regeneration and enforces consolidation of titanium implant into a new rat caudal vertebrae model.Pathol Oncol Res. 2009; 15(4):567-577.[38] Gao Y,Luo E,Hu J,et al.Effect of combined local treatment with zoledronic acid and basic fibroblast growth factor on implant fixation in ovariectomized rats.Bone. 2009;44(2):225-232.[39] Li YF,Li XD,Bao CY,et al.Promotion of peri-implant bone healing by systemically administered parathyroid hormone (1-34) and zoledronic acid adsorbed onto the implant surface. Osteoporos Int. 2013;24(3): 1063-1071.[40] Peter B,Pioletti DP,Laib S,et al.Calcium phosphate drug delivery system: influence of local zoledronate release on bone implant osteointegration.Bone.2005;36(1):52-60.[41] Kettenberger U,Luginbuehl V,Procter P,et al.In vitro and in vivo investigation of bisphosphonate-loaded hydroxyapatite particles for peri-implant bone augmentation. J Tissue Eng Regen Med. 2017;11(7): 1974-1985.[42] Li G,Zhang L,Wang L,et al.Dual modulation of bone formation and resorption with zoledronic acid-loaded biodegradable magnesium alloy implants improves osteoporotic fracture healing: An in vitro and in vivo study.Acta Biomater. 2018;65:486-500.[43] Rugani P,Kirnbauer B,Acham S,et al.Implant Placement Adjacent to Successfully Treated Bisphosphonate-Related Osteonecrosis of the Jaw(BRONJ).J Oral Implantol. 2015;41:377-381.[44] Marínfernández AB,García MB,Aguilarsalvatierra A,et al.Jaw osteonecrosis management around a dental implant inserted 2 years before starting treatment with zoledronic acid.J Clin Exp Dent. 2015; 7(3):e444.[45] Miniello TG,Araújo JP,Lopes RN,et al.Osteonecrosis related to once-yearly zoledronic acid treatment in an osteoporotic patient after dental implant.Braz Dent J.2015;26(1):86-88.[46] Ata-Ali J, Ata-Ali F,Penarrocha-Oltra D,et al.What is the impact of bisphosphonate therapy upon dental implant survival? A systematic review and meta-analysis.Clin Oral Implants Res.2016; 27(2):e38-46.[47] Kim JW,Baik J,Jeon JH.Dental implant treatment after healing of bisphosphonate-related osteonecrosis of the jaw (BRONJ) in the same region: a case report.J Korean Assoc Oral Maxillofac Surg. 2016;42(3): 157-161.[48] Siebert T,Jurkovic R,Statelova D,et al.Immediate Implant Placement in a Patient With Osteoporosis Undergoing Bisphosphonate Therapy: 1-Year Preliminary Prospective Study.J Oral Implantol. 2015;41: 360-365.[49] Al-Sabbagh M,Robinson FG,Romanos G,et al.Osteoporosis and bisphosphonate-related osteonecrosis in a dental school implant patient population.Implant Dent.2015;24(3):328-332.[50] Mattheos N,Caldwell P,Petcu EB,et al.Dental implant placement with bone augmentation in a patient who received intravenous bisphosphonate treatment for osteoporosis.J Can Dent Assoc. 2013; 79:d2. |
.jpg)
.jpg)